Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over

NCT00170768 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
May 31, 2005
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers